TGTX
TGTX
US88322Q1085
TG Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
8.48B EUR
8.41B EUR
5.09B EUR
4.63B EUR
Enterprise Value
7.77B EUR
8.68B EUR
5.4B EUR
4.8B EUR
Valuation Multiples
Trailing P/E
20.13x
19.05x
11.01x
10.47x
Forward P/E
20.45x
--
--
--
Price to Sales
10.6x
10.52x
7.26x
9.34x
Price to Book
13.46x
13.92x
8.72x
7.14x
EV/Revenue
9.72x
10.86x
7.71x
9.7x
EV/EBITDA
56.93x
58.45x
33.87x
39.35x
Price to FCF (P/FCF)
143.32x
483.76x
--
1,233.26x
EV/FCF
131.37x
499.39x
--
1,279.76x
FCF Yield
0.7%
0.21%
-0.28%
0.08%
ende